2VF0

HEMOSTEMIX INC.

Healthcare · EUR · F

2VF0

Price

€0.02

-16.67%

Cap

€3.96M

Earnings

30d Trend

-50.0%

2VF0
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

97% annualised over 90 days

BRAIN47 SIGNAL

0
MODERATE
Risk Level66
Quality30
Momentum61
Technical33
Fundamentals50

Raw weighted: 41×Macro 0.99 (1%)=41

RISK

66/100
90d Volatility
96.9%High
ATR %
0.0%Low daily moves
Max Drawdown (1Y)
-67.2%Volatile

QUALITY

30/100
ROE (avg)
0.0%Weak
Piotroski F-Score
2/9Weak
Accruals
-21.1%Cash earnings

MOMENTUM

61/100
12-1M Momentum
+12.5%Strong uptrend
6-1M Momentum
+8.8%Positive
1M Return
-50.0%Sharp decline

TECHNICAL

33/100
RSI (14)
9.0Oversold
Price vs SMA200
-50.0%Bearish trend
MACD
-0.01Bearish momentum
Bollinger Band
33%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.833Clean trend

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months61
3-12 months31
1-5+ years36

5-10 day swing — oversold bounce candidate

BRAIN47'S ASSESSMENT

I rate HEMOSTEMIX INC. at 41/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 61/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

-50.0%

3 MONTHS

-50.0%

12 MONTHS

-37.5%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

5-10 day swing — oversold bounce candidate. Momentum (61) and Fundamentals (50) are the primary strengths. I note that quality is the weakest area at 30/100 — this warrants monitoring. Historical volatility is elevated at 97%. I classify this as a speculative position — elevated volatility at 97% and smaller market cap define the opportunity.

speculativeScore: 41/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.